Efficacy of Suxiao Jiuxin Pill on Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials

Evidence-based Complementary and Alternative Medicine : ECAM
Li RenJun Li

Abstract

Suxiao jiuxin pill is considered an effective ancillary drug in patients with coronary heart disease. Although numerous small, single-center clinical trials have been conducted, the benefits and harms of suxiao jiuxin pill remain controversial. We performed a meta-analysis to clarify the efficacy of suxiao jiuxin pill on patients with coronary heart disease. Randomized controlled trials were identified by using the Cochrane Library, PubMed, Web of Science, Embase, Wanfang, Weipu, and China Knowledge Resource Integrated databases (until June 2016). Pooled relative risks (RR), weighted mean differences (WMD), and 95% confidence intervals (95% CIs) were estimated using random-effects models. Forty-one trials involving 6276 patients were included in our analysis. Administration of suxiao jiuxin pill significantly improved electrocardiogram (ECG) results when compared with other therapies (RR 1.32, 95% CI 1.26 to 1.38, and P < 0.001). Subgroup analyses revealed that suxiao jiuxin pills improve ECG results more than salvia tablets (RR 1.54, 95% CI 1.41 to 1.67, and P < 0.001), isosorbide dinitrate (RR 1.14, 95% CI 1.21 to 1.44, and P = 0.001), nitroglycerin (RR 1.35, 95% CI 1.16 to 1.56, and P < 0.001), and other drugs (RR 1.32, 95% ...Continue Reading

References

Aug 1, 1983·American Heart Journal·W B KannelP M McNamara
Feb 1, 1996·Controlled Clinical Trials·A R JadadH J McQuay
Jan 26, 2000·International Journal of Cardiology·S LokshynV Kuhlkamp
Jul 12, 2002·Statistics in Medicine·Simon G Thompson, Julian P T Higgins
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jun 27, 2006·Scandinavian Cardiovascular Journal : SCJ·Jan Erik OtterstadUNKNOWN Action Investigators
Jul 22, 2008·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·S P BhatiaA M Api
Oct 8, 2011·Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan·Chun-Shen L iFei Han
Oct 22, 2011·Pharmaceutical Biology·Xia RanLu-Ping Qin
Sep 8, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Weixia LiJin-Ao Duan
May 9, 2014·Evidence-based Complementary and Alternative Medicine : ECAM·Xiao-Yan BaiGuo-Wei He
Oct 21, 2015·BMC Complementary and Alternative Medicine·Zhiqiang LuYongling Tong
Nov 13, 2015·Journal of Integrative Medicine·Eric Wei Chiang Chan, Siu Kuin Wong
Apr 7, 2016·Vascular Health and Risk Management·Rouba Karen ZeidanAtul Pathak
Apr 27, 2016·American Journal of Preventive Medicine·Sung Sug Sarah YoonMargaret Carroll

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.